Quantitative Sensory Testing in Subjects With Sensitive Skin or Not
NCT ID: NCT03081403
Last Updated: 2025-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2017-04-14
2017-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Quantitative sensory testing (QST) is a physico-psychic method that uses gradients stimuli of different modalities to measure a subjective somatosensory response. This allows to characterize sensory dysfunction by assessing the participation of small and large nerve fibers.
The aim of this project is to characterize the presence or absence of a neurological disorder in patients with sensitive skin. This discovery would be a decisive argument to reinforce the suspicion that sensitive skins is linked to a small fiber neuropathy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of QST to Characterize Somatosensory Functionality
NCT06439004
QST and Neuropathic Pain
NCT03806010
Changes in Sensory Perception During Hypnotic Relaxation
NCT02261155
Impact on Pain Sensitivity of Clinical Interaction
NCT04888026
Flexible Attention Sensory Training for Youth with Chronic Pain
NCT06051305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Quantitative sensory testing (QST) is a physico-psychic method that uses gradients stimuli of different modalities to measure a subjective somatosensory response. This allows to characterize sensory dysfunction by assessing the participation of small and large nerve fibers.
The aim of this project is to characterize the presence or absence of a neurological disorder in patients with sensitive skin. This discovery would be a decisive argument to reinforce the suspicion that sensitive skins is linked to a small fiber neuropathy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with sensitive skin
Subjects with a score greater than 50 on the sensitive scale
Quantitative Sensory Testing
Study of detection thresholds of vibration, cold and pain related to the heat in the dominant hand of the subjects through the QST.
Subjects without sensitive skin
Subjects with result lower than 20 on the sensitive scale
Quantitative Sensory Testing
Study of detection thresholds of vibration, cold and pain related to the heat in the dominant hand of the subjects through the QST.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantitative Sensory Testing
Study of detection thresholds of vibration, cold and pain related to the heat in the dominant hand of the subjects through the QST.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cooperating patient
* Informed and written consent of the subject
* Affiliated to the social security
* For subjects with sensitive skin:
subjects with a score greater than 50 on the scale sensitive scale
\- To control subjects: subjects with result of less than 20 sensitive to the scale scale
Exclusion Criteria
* Subject in a social institution.
* Subject with major cognitive or psychiatric disorders
* Subject with pathological use of alcohol or consumption of another drug.
* Subject with skin involvement of the back of the dominant hand or malformation.
* Known sensitive neuropathy
* Pregnant woman
* Subject receiving medical treatment which may interfere with the results.
* Subject with treatment in the back of the dominant hand.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SENSISKIN 29CRB16.0100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.